Vertex Pharmaceuticals Inc. (VRTX) Stock Quote

Detailed Quote for Vertex Pharmaceuticals Inc. (VRTX)

After Hours: $ 36.2197

0.0897 (+0.25%)

Volume: 5.76 k

4:39 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

May 12, 2011

Close: 58.87

52 Week Low

November 25, 2011

Close: 26.50

Today

Last Price
36.13

Change $
0.91

Change %
2.46%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
36.83

High
37.00

Low
36.06

Prev Close
37.04

Last Trade
2/10/12

Volume
1.78 m

52 Wk Hi
58.87

52 Wk Low
26.50

Market Cap
7.54 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
208,566,194

EPS (TTM)
0.14

PE Ratio
258.10

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Vertex Pharmaceuticals Inc. (VRTX)

Sector News | Topic News

News for VRTX

Fri, Feb 03, 2012

10:09 AM

"Stock Alerts" on Fire With 100% Profitable Trades to Start 2012 - Marketwire

Thu, Feb 02, 2012

4:00 PM

Vertex Reports Fourth Quarter and Full-Year 2011 Financial Results - Business Wire

9:00 AM

Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Pfizer Inc. - Marketwire

Tue, Jan 31, 2012

11:24 AM

ADDING MULTIMEDIA FDA Approves KALYDECO(tm) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis - Business Wire

Tue, Jan 17, 2012

9:15 AM

Vertex Announces the Date of its Full Year 2011 Financial Results Conference Call and Webcast - Business Wire

Sun, Jan 08, 2012

8:16 PM

Vertex Announces Key 2012 Business Objectives as Company Prepares for Planned Global Launch of KALYDECO in Cystic Fibrosis - Business Wire

Wed, Jan 04, 2012

9:00 AM

Vertex Announces Webcast of its Presentation at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Thu, Dec 15, 2011

7:46 AM

FDA Grants Priority Review for KALYDECO(tm) (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis - Business Wire

7:45 AM

Vertex Announces CEO Succession Plan for 2012 - Business Wire

Fri, Dec 09, 2011

8:30 AM

Vertex and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C - Business Wire

Mon, Nov 28, 2011

9:01 AM

Direction of Market Influences - Report Highlights Vertex Pharmaceuticals Incorporated and Deckers Outdoor Corporation - Marketwire

Tue, Nov 22, 2011

4:15 PM

Vertex Pharmaceuticals Announces Webcast of its Presentation at the 23rd Annual Piper Jaffray Health Care Conference - Business Wire

Thu, Nov 17, 2011

9:00 AM

Steps in the Right Direction - Featured Research on Vertex Pharmaceuticals Incorporated and Sunwin International Neutraceuticals Inc - Marketwire

Tue, Nov 08, 2011

8:16 AM

Promising Studies From Inhibitex Take Wind Out of Vertex Pharmaceutical's Sails - Marketwire

Tue, Oct 11, 2011

9:06 AM

Analyst View, Impact of Global Events - Research Report on Vertex Pharmaceuticals Incorporated and Ryder System, Inc. - Marketwire

Fri, Sep 23, 2011

9:30 AM

Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals - PR Newswire

Wed, Jun 29, 2011

9:00 AM

Research Report on Vertex Pharmaceuticals Inc. and PharmAthene, Inc. - Gaining in the Bio Pharmaceutical Sector - Marketwire

Tue, Jun 21, 2011

9:11 AM

Analyst Research on Warner Chilcott plc and Vertex Pharmaceuticals Incorporated - Drug Manufacturers - Other Sector's Brain on Marketing - Marketwire

Mon, May 23, 2011

11:22 PM

FDA approves drug for hepatitis C - UPI

Thu, Apr 28, 2011

1:58 AM

FDA set to approve drug for hepatitis C - UPI

More News for VRTX >>

Tags for Vertex Pharmaceuticals Inc.

Research stocks or mutual funds related to Vertex Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to VRTX. The keywords below have been associated to VRTX by either user submission or electronic means.

life sciences market research biotechnology company aventis pharmaceuticals biotech research haglof vertex pharmaceuticals research pharmaceuticals international research clinical trials liability vertex pharmaceuticals stock clinical research trial hcv protease senior health care clinical trials data stock recommendations pharmaceuticals companies pharmaceuticals logistics niche pharmaceutical vrtx vertex vxa 710 coopervision vertex toric biotechnology market pharmaceutical research and development biotech jobs stock investment dupont pharmaceuticals historical stock market data stock market investment consumerism in health care health care administrator health claims specialist pharmaceuticals jobs health care consumerism novartis pharmaceuticals pharmaceuticals supply chain research biotechnology jobs clinical research pharmaceutical cro stock market news letter vertex hypsometer vertex contact lenses health care report dakine vertex pack stock recommendation health care marketing vertex sphere contact lenses pharmaceutical sales abo pharmaceuticals clinical trials industry health fairs